Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linli Li

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Cell Cycle (Georgetown, Tex.)|March 9, 2021
Exosomes derived from autologous dermal fibroblasts promote diabetic cutaneous wound healing through the Akt/β-catenin pathwayXinye Han, Peipei Wu, Linli Li, et al.
Journal of Medicinal Chemistry|April 19, 2019
Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor BromodomainLuyi Huang, Hui Li, Linli Li, et al.
European Journal of Medicinal Chemistry|February 20, 2022
Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivoHuachao Bin, Pei Chen, Ming Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2022
Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitorsPei Chen, Huachao Bin, Yan Jiao, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2020
Discovery of small molecule FLT3 inhibitors that are able to overcome drug-resistant mutationsGuo Zhang, Wenqing Zhang, Chenjian Shen, et al.
Journal of Medicinal Chemistry|January 5, 2022
Discovery of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer EffectsYueshan Li, Liting Zhang, Ruicheng Yang, et al.
Journal of Chemical Information and Modeling|March 17, 2017
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship AnalysisShenzhen Huang, Chunli Song, Xiang Wang, et al.
ACS Biomaterials Science & Engineering|February 14, 2024
Anatomical Brushite-Coated Mg-Nd-Zn-Zr Alloy Cage Promotes Cervical Fusion: One-Year Results in GoatsHaiyuan Yang, Fan Zhang, Haocheng Xu, et al.
Bioorganic Chemistry|December 15, 2023
Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groupsQiao Huang, Baoxue Quan, Yan Chen, et al.
Journal of Nanobiotechnology|August 2, 2022
Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targetingPeipei Wu, Yuting Tang, Can Jin, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Cell Cycle (Georgetown, Tex.)|March 9, 2021
Exosomes derived from autologous dermal fibroblasts promote diabetic cutaneous wound healing through the Akt/β-catenin pathwayXinye Han, Peipei Wu, Linli Li, et al.
Journal of Medicinal Chemistry|April 19, 2019
Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor BromodomainLuyi Huang, Hui Li, Linli Li, et al.
European Journal of Medicinal Chemistry|February 20, 2022
Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivoHuachao Bin, Pei Chen, Ming Wu, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2022
Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitorsPei Chen, Huachao Bin, Yan Jiao, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2020
Discovery of small molecule FLT3 inhibitors that are able to overcome drug-resistant mutationsGuo Zhang, Wenqing Zhang, Chenjian Shen, et al.
Journal of Medicinal Chemistry|January 5, 2022
Discovery of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer EffectsYueshan Li, Liting Zhang, Ruicheng Yang, et al.
Journal of Chemical Information and Modeling|March 17, 2017
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship AnalysisShenzhen Huang, Chunli Song, Xiang Wang, et al.
ACS Biomaterials Science & Engineering|February 14, 2024
Anatomical Brushite-Coated Mg-Nd-Zn-Zr Alloy Cage Promotes Cervical Fusion: One-Year Results in GoatsHaiyuan Yang, Fan Zhang, Haocheng Xu, et al.
Bioorganic Chemistry|December 15, 2023
Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groupsQiao Huang, Baoxue Quan, Yan Chen, et al.
Journal of Nanobiotechnology|August 2, 2022
Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targetingPeipei Wu, Yuting Tang, Can Jin, et al.
Pageof 14